World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
141
Citations
144734
World Ranking
1580
National Ranking
922

John B. Buse publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where John B. Buse sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 591 publications — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

John B. Buse D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where John B. Buse sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 141 D-Index — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

John B. Buse is affiliated with the University of North Carolina at Chapel Hill in the United States. Their research primarily falls within the field of Medicine, with a significant focus on Endocrinology, Diabetes and Metabolism. Additional subfields of study include Molecular Biology, Surgery, Genetics, and Infectious Diseases.

Their work addresses several main topics including:

  • Diabetes Treatment and Management
  • Diabetes Management and Research
  • Metabolism, Diabetes, and Cancer
  • Pancreatic function and diabetes
  • Diabetes and associated disorders
  • COVID-19 Clinical Research Studies
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients

John B. Buse has contributed to numerous publications with frequent appearances in the following venues:

  • UNC Libraries
  • Diabetes Care
  • Diabetes
  • Diabetes Obesity and Metabolism
  • Journal of Clinical and Translational Science

Some of the recent papers they contributed to include:

  • Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD), 2022, Diabetes Care
  • Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD), 2022, Diabetologia
  • Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection, 2023, JAMA
  • Glucose-responsive insulin patch for the regulation of blood glucose in mice and minipigs, 2020, Nature Biomedical Engineering
  • Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin, 2021, JAMA

Frequent co-authors of John B. Buse include:

  • Til Stürmer
  • Carolyn T. Bramante
  • Steven E. Kahn
  • Richard E. Pratley
  • Klara R. Klein

Best Publications

  • Effects of intensive glucose lowering in type 2 diabetes

    Hertzel C Gerstein;Michael E Miller;Robert P Byington

  • Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

    Steven P. Marso;Gilbert H. Daniels;Kirstine Brown-Frandsen;Peter Kristensen

  • Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement of the American Diabetes Association and the European Association for the Study of Diabetes

    David M. Nathan;John B. Buse;Mayer B. Davidson;Ele Ferrannini

  • Management of hyperglycemia in type 2 diabetes: A patient-centered approach: Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    Silvio E. Inzucchi;Richard M. Bergenstal;John B. Buse;Michaela Diamant

  • Effects of intensive blood-pressure control in type 2 diabetes mellitus.

    C. Cushman;Gregory W. Evans;Robert P. Byington;Jeffrey A. Cutler

  • Effects of combination lipid therapy in type 2 diabetes mellitus.

    Henry N. Ginsberg;Laura C. Lovato;Lawrence A. Leiter;Peter Linz

  • Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    Silvio E Inzucchi;Richard M Bergenstal;John B Buse;Michaela Diamant

  • Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    Melanie J. Davies;David A. D’Alessio;Judith Fradkin;Walter N. Kernan

  • The Metabolic Syndrome: Time for a Critical Appraisal Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

    Richard Kahn;John Buse;Ele Ferrannini;Michael Stern

  • Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus A scientific statement from the American Heart Association and the American Diabetes Association

    John B. Buse;Henry N. Ginsberg;George L. Bakris;Nathaniel G. Clark

  • Follow-up report on the diagnosis of diabetes mellitus.

    Saul Genuth;K. G M M Alberti;Peter Bennett;John Buse

  • International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes

    David M. Nathan;Beverly Balkau;Enzo Bonora;Knut Borch-Johnsen

  • Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

    Jennifer B Green;M. Angelyn Bethel;Paul W Armstrong;John B Buse

  • Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

    Silvio E. Inzucchi;Richard M. Bergenstal;John B. Buse;Michaela Diamant

  • Method for integrated sample acquisition and analyte measurement device

    John Bernard Buse;Alan Charles Moses

  • Strategies for Multivessel Revascularization in Patients with Diabetes

    Michael E. Farkouh;Michael Domanski;Lynn A. Sleeper;Flora S. Siami

  • Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.

    Rury R. Holman;M. Angelyn Bethel;Robert J. Mentz;Vivian P. Thompson

  • Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).

    John B Buse;Julio Rosenstock;Giorgio Sesti;Wolfgang E Schmidt

  • [Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. (A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes)].

    D M Nathan;J В Buse;M В Davidson;R J Heine

  • Erratum: Management of hyperglycaemia in type 2 diabetes: A patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (Diabetologia (2013) 56 (680))

    S. E. Inzucchi;R. M. Bergenstal;John B Buse;M. Diamant

Frequent Co-Authors

Rury R. Holman
Rury R. Holman University of Oxford
Michael A. Nauck
Michael A. Nauck Ruhr University Bochum
Anne L. Peters
Anne L. Peters University of Southern California
Zhen Gu
Zhen Gu Zhejiang University
Til Stürmer
Til Stürmer University of North Carolina at Chapel Hill
Darren K. McGuire
Darren K. McGuire The University of Texas Southwestern Medical Center
Ele Ferrannini
Ele Ferrannini University of Pisa
Bernard Zinman
Bernard Zinman University of Toronto
Julio Rosenstock
Julio Rosenstock The University of Texas Southwestern Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a future in Medicine isn’t limited to the traditional MD route. Diverse online degrees and flexible career pathways can help students launch or advance in various healthcare roles. For registered nurses aiming for more autonomy and career growth, adn to fnp bridge programs provide an efficient way to move from an Associate Degree in Nursing to a Family Nurse Practitioner qualification.

Nutrition is another vital area in healthcare. Those interested in dietary science and wellness can pursue an online degree in nutrition, opening doors to roles in clinical settings, public health, and education. If your ambitions lie in healthcare administration, consider official and reputable best mha programs to train for management and leadership positions within medical organizations.

Many professionals seek flexible learning options. For registered nurses, online rn-bsn programs without clinicals allow you to advance your credentials while balancing work and personal commitments. These pathways all contribute to a robust healthcare system—no matter which you choose, online learning offers flexible, career-focused opportunities in medicine and related fields.

Best Scientists Citing John B. Buse

Trending Scientists

Recently Published Articles